While there is no previous evidence that IGFBP6 is deleterious to kidney function, its gene expression is upregulated in CKD [33] and its levels have been shown to decrease in adults with kidney failure requiring kidney replacement therapy post-transplantation [34]. The gene discussed is IGFBP6; the disease is kidney failure.